Central Drugs Standard Control Organization

Directorate General of Health Services
Ministry of Health & Family Welfare
Government of India

Downloads/Documents & Publications

S.No.
Title Downlaod (pdf) File Size
1 Guidance document for Veterinary Biologicals 2478 KB
2 Annual performance Appraisal Reports (ACR group C)(Related to Employees) 3,030kb
3 Travelling allowance bill for tour(Related to Employees) 334kb
4 Application for leave or for extension of leave(Related to Employees) 979kb
5 Leave Travel Concession Bill(Related to Employees) 1,631kb
6 TRAVELLING ALLOWANCE BILL FOR TRANSFER 622kb
7 Organ(s) and tissue(s) Donor Form 254kb
8 Advance LTC Form(Related to Employees) 334kb
9 Joining Report after EL 121kb
10 Assessment report Form 1,396kb
11 Nomination Form 2,723kb
12 Annual performance Appraisal Reports (ACR group A-B)(Related to Employees) 2,540kb
13 Medical reimbursement claim Form(Related to Employees) 484kb
14 Application for withdrawal from G.P.F Form(Related to Employees) 243kb
15 Adverse Drugs Reaction Reporting Form 712kb
16 Annexure Sheet for submit the Application Form(For Stakeholders) 64kb
17 Guidelines under new penal Provision 199kb
18 Challan (TR-6) for depositing fee(For Stakeholders) 10kb
19 Good Manufacturing Practices 282kb
20 Proforma for Drugs Controller Reporting activities 13kb
21 Right to Information Act, 2005 (RTI) - Application Form 56kb
22 Application for advance G.P.F Form(Related to Employees) 957kb
23 The Drugs & Cosmetics (Amendment) Act, 2008 and Guidelines 5,058kb
Date
Documents Pdf
1 SB3 249 KB
2 Baricitinib eli lily 509 KB
3 TRUNCATE – TB (tuberculosis) 3884 KB
4 Lenvatinib Capsules 4 mg and 10 mg 330 KB
5 Ticagrelor 120/180 mg SR Tablet 2652 KB
6 AUR101 3310 KB
7 Desidustat Tablet versus Epoetin alfa Injection 2558 KB
8 PNB-001 267 KB
9 Zileuton Ointment 1.25% and 5.0% 702 KB
10 Etrasimod( IQVIA RDS) 513 KB
11 Etrasimod( IQVIA) 502 KB
12 Etrasimod 485 KB
13 FEIBA 403 KB
14 CT-P13 471 KB
15 Inotuzumab 370 KB
16 Iodixanol 2023 KB
17 LNP023 366 KB
18 Concizumab Prophylaxis 508 KB
19 Concizumab 327 KB
20 LNP023(Rituximab) 260 KB
21 Oral Baricitinib 503 KB
22 Avanafil tablets 100 mg & 200 mg 1223 KB
23 Brazikumab 491 KB
24 GSK3196165 284 KB
25 Ruxolitinib 310 KB
26 Apremilast Film Coated 10/10/30mg Tablets 2755 KB
27 Spironolactone Topical Cream 5% 1495 KB
28 Tenofovir Alafenamide, Emtricitabine and Bictegravir 2682 KB
29 Sofosbuvir 400 mg Tablet 2627 KB
30 Methylcobalamin Nasal spray 500 mcg 284 KB
31 Certican / Zortress(everolimus EVR) 312 KB
32 Tirzepatide1 313 KB
33 Tirzepatide 313 KB
34 QL1205 Versus Lucentis 304 KB
35 HP-hMG and Menopur® 2143 KB
36 AT-10 (2-oxoclopidogrel bisulfate 2845 KB
37 Brazikumab 393 KB
38 semaglutide versus placebo 477 KB
39 Ribociclib plus goserelin acetate 434 KB
40 evenamide or placebo 273 KB
41 Meningococcal Conjugate Vaccine 510 KB
42 Leuprolide acetate 2291 KB
43 ligelizumab (QGE031) 328 KB
44 MYL-1701P and Eylea 299 KB
45 Netarsudil Ophthalmic solution 0.02% 3055 KB
46 Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial) 710 KB
47 Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial) 710 KB
48 Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial) 710 KB
49 Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Cilnidipine IP film coated tablet (Phase III Clinical Trial) 697 KB
50 Efonidipine Hydrochloride Ethanolate + Telmisartan IP + Chlorthalidone IP Tablets (Phase III Clinical Trial 705 KB
51 Mirikizumab 625 KB
52 Azelnidipine IP + Chlorthalidone IP Uncoated Tablet (Phase III Clinical Trial) 617 KB
53 Tranexamic acid 1667 KB
54 Menopausal Gonadotropin 2618 KB
55 k0706 592 KB
56 baloxavir marboxil 492 KB
57 traconazole 1373 KB
58 Semaglutide 2366 KB
59 Mirikizumab (UC) 625 KB
60 Semaglutide (SOUL) 2366 KB
61 Filgotinib (rheumatoid Arthritis) 519 KB
62 Filgotinib 591 KB
63 Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial) 531 KB
64 Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial) 531 KB
65 Capivasertib + Paclitaxel versus placebo 228 KB
66 Tigilanol Tiglate 368 KB
67 Baricitinib 500 KB
68 Evenamide 608 KB
69 Oral Baricitinib 316 KB
70 Baricitinib 500 KB
71 HD204 to Avastin® 513 KB
72 Aceclofenac Topical ointment 1.5% w/wIII 2285 KB
73 Beclomethasone 1765 KB
74 Evenamide 608 KB
75 Ulipristal acetate tablet 30mgIII 2555 KB
76 IVIEW-1201 264 KB
77 Sertaconazole Nitrate + Terbinafine HCl cream (Phase III Clinical Trial) 643 KB
78 Ribiciclib 289 KB
79 INTP24 against Avastin® in 468 KB
80 PMZ-1620 320 KB
81 Benidipine Hydrochloride JP + Chlorthalidone IP Film coated tablets (Phase III Clinical Trial 580 KB
82 Benidipine Hydrochloride + Metoprolol Succinate eq. to Metoprolol tartrate IP Film coated tablet (Phase III Clinical Trial) 357 KB
83 Adenosine IP + Minoxidil IP Topical solution (Phase II Clinical Trial) 626 KB
84 AS012 230 KB
85 Lenalidomide 267 KB
86 Osimertinib in Combination with Savolitinib 492 KB
87 Crizanlizumab 303 KB
88 Biapenem 300 mg inj 368 KB
89 Saroglitazar tablet 4mg II 2058 KB
90 Sulbactam-ETX2514 427 KB
91 Rifapentine plus Isoniazid 259 KB
92 Acotiamide ER tablet 300 tabletIII 2090 KB
93 Ropivacaine Readyfusor 2mg/mlIII 2629 KB
94 IQVIA 213 KB
95 Toujeo 300 Units/ml 486 KB
96 Oral Galactose 252 KB
97 Guselkumab 566 KB
98 Semaglutide (NN9535-4352) 429 KB
99 Semaglutide 429 KB
100 Curcumin (Biocurcumax cap) as an adjunct drug to standard therapy [(Artesunate) + (Sulfadoxine-Pyrimethamine) tablet] 238 KB
101 2Ó-Methyl-Phosphorothioate Anti Sense Oligoribonucleotide for treating patients with Duchenne Muscular Dystrophy 231 KB
102 Xlucane versus Lucentis® 443 KB
103 Durvalumab 427 KB
104 Neoadjuvant/adjuvantDurvalumab 427 KB
105 Rituximab Biosimilar (DRL_RI) with MabThera® 434 KB
106 Baricitinib 194 KB
107 Phenobarbital Sodium Injection 191 KB
108 METREXASSIST™ 194 KB
109 Tirzepatide 432 KB
110 FDC of Daclatasvir Dihydrochloride Eq. to Daclatasvir 60mg Sofosbuvir 400mg film coated tablets (Phase IV) 1031 KB
111 C.O.M.B.A.T 222 KB
112 Sodium Fusidate eq. To Fusidic acid 2% w/w (Sofinox gel) 3105 KB
113 Saroglitazar 2mg & 4mg Tablet 2767 KB
114 Oral Nafithromycin vs oral Moxifloxacin 417 KB
115 TRC160334 295 KB
116 Olaparib 250 KB
117 Rivaroxaban tablets 2.5mg (Xarelto®) 2579 KB
118 Tacrolimus lipid tablet 3mg 2677 KB
119 Fitusira 419 KB
120 SB12 and Soliris 202 KB
121 Galcanezumab 327 KB
122 Durvalumab 208 KB
123 SAR341402 Mix 70/30 to NovoMix®3 337 KB
124 Lasmiditan 334 KB
125 Norditropin® 427 KB
126 Pharmacokinetic and Pharmacodynamic 476 KB
127 Pharmacokinetics of Murepavadin 248 KB
128 IMU-131 HER2/neu 427 KB
129 Ipatasertib in Combination with Paclitaxel 194 KB
130 Cetilistat 394 KB
131 Octenidine Dihydrochloride 318 KB
132 Bedaquiline, Delamanid, Linezolid and Clofazimine 267 KB
133 Bibrocathol 2% Eye ointment 303 KB
134 Probiotic Supplementation lactic acid bacteria and Bifidobacteria, namely, L. Plantarum DSM24730, L. paracasei DSM 24733, L. delbrueckii subsp. Bulgaricus DSM 24734, L. acidophilus DSM24735, B. longam, DSM24736, B. Infantis DSM 24737, B. breve DSM 24732, and S. thermophilus DSM 24731 which is to be reconstituted with MCT oil drop with Medium Chain Triglyceride (MCT) oil 2042 KB
135 Norethisterone CR tablet 15mg 2068 KB
136 Teneligliptin and Sitagliptin 247 KB
137 secukinumab SUNSHINE 570 KB
138 Edoxaban tosylate 220 KB
139 iGlarLixi versus premixed 321 KB
140 Secukinumab SUNRISE 570 KB
141 Durvalumab in combination 423 KB
142 Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil Cilnidipine film coated bilayaered tablet (Phase III) 1652 KB
143 Alfuzosin Hydrochloride IP (extended release form) Tadalafil IP film coated tablets (Phase III) 1141 KB
144 Evaluation of Vitamin D Supplementation in affecting the outcome of newly Diagnosed patients with Lymphoma 217 KB
145 Oxaceprol tablet 600mg 1358 KB
146 Tacrolimus lipid suspension 4mg/vial 1294 KB
147 Baricitinib SLE 581 KB
148 Beclomethasone Dipropionate 581 KB
149 Bepotastine besilate JP Montelukast Sodium IP tablets (Phase III) 1067 KB
150 Ofatumumab toterability 195 KB
151 Durvalumab Monotherapy 355 KB
152 Ivermectin Lotion,0.5% 223 KB
153 Phase 3 Relamorelin 413 KB
154 JHL1101 498 KB
155 Benidipine Hydrochloride IP Telmisartan IP Film coated tablets (Phase III) 1695 KB
156 Relamorelin gastroparesis 238 KB
157 efficacy ART-123 439 KB
158 Mirabegron (in extended release) Solifenacin Succinate Film coated bilayered tablets (Phase III) 1117 KB
159 SHP640 196 KB
160 Teriflunomide tab 14 mg 428 KB
161 PNB028 266 KB
162 Durvalumab plus Olaparib 1481 KB
163 HRF-4467 228 KB
164 Prednisone delayed Release Tablet 5 mg 2670 KB
165 Itraconazole 1378 KB
166 Durvalumab as Consolidation therapy 1497 KB
167 Relamorelin 1680 KB
168 Enbrel®’ (Etanercept 1379 KB
169 Dexamethasone Sodium Phosphate 1600 KB
170 Single dose Del Nido vs multi dose StThomas II Cardioplegia 235 KB
171 CPL-2009-0031 tablet 140 mg 277 KB
172 PMZ-2010 283 KB
173 CPL-2009-0031 tablet 140 mg of Cadila Pharmaceutical Ltd 222 KB
174 Azacitidine 239 KB
175 Durvalumab 1405 KB
176 Pembrolizumab 1412 KB
177 LNP3794 in apatients 1411 KB
178 Crizanlizumab 1410 KB
179 Dupilumab 1781 KB
180 Ifetroban 1415 KB
181 CT-P16 1586 KB
182 Ivabradine Tablets 2291 KB
183 TX05 1595 KB
184 Herceptin® or TX05 1438 KB
185 Selinexor (KPT-330 1592 KB
186 NexoBrid 1513 KB
187 ZS (sodium zirconium cyclosilicate 1636 KB
188 ligelizumab (QGE031) 1696 KB
189 Cefepime-Tazobactam vs. Meropenem 1484 KB
190 Ligelizumab (QGE031) 1614 KB
191 PXL01 1568 KB
192 Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5% 1449 KB
193 Coversin 1489 KB
194 Aztreonam-Avibactam (Atm-Avi) 1491 KB
195 Semaglutide 1601KB
196 tropifexor (LJN452) and cenicriviroc (CVC) 1460 KB
197 Azelnidipine tab 8 mg / 16 mg 287 KB
198 Azacitidine 100 mg 280 KB
199 Epinephrine plus Vasopressin 226KB
200 Saroglitazar Magnesium 17176 KN
201 Azelnidipine 371 KB
202 VELPANAT 197 KB
203 FDC of Efonidipine Hydrochloride Ethanolate + Metoprolol Succinate IP (as extended release) (20 mg+25mg & 20mg+50mg) Film coated tablets. 17177 KB
204 Doxycycline 225 KB
205 Pregabalin 212 KB
206 Bedaquiline, Delamanid, Linezolid and Clofazimine 218 KB
207 PMZ-1620 259 KB
208 Tulobuterol Transdermal 239 KB
209 Desidustat ZYAN1 236 KB
210 Enterogermina 179 KB
211 Nexagon® (NEXAGON) 1530 KB
212 Tapentadol nasal spray 225mg/ml 966 KB
213 Semaglutide 1637 KB
214 LCZ696 1762 KB
215 Ticagrelor 1672 KB
216 Osilodrostat (LCI699 1794 KB
217 Mirikizumab 1850 KB
218 Efpeglenatide 444 KB
219 KAF156 1902 KB
220 Nitazoxanide 500 mg Tablets 1696 KB
221 Brolucizumab 1822 KB
222 5-aminolevulinic acid hydrochloride 1845 KB
223 Edoxaban 1794 KB
224 EG12014 1782 KB
225 Mirikizumab 1786 KB
226 Granexin Gel 545 KB
227 Aztreonam-Avibactam (ATM-AVI Pfizer 2029 KB
228 Esmolol Hydrochloride 14.00% w/w topical gel 1298 KB
229 FDC of Daclatasvir dihydrochloride eq to Daclatasvir 60mg + Sofosbuvir 400mg film coated tablets 1246 KB
230 Clostridium Botulinum Type-A Toxin Haemagglutinin complex injection 300 units 1737 KB
231 Dalfampridine 124 KB
232 Osimertinib 1773 KB
233 Apremilast Tablets 10/20/30mg Phase IV . 1708 KB
234 FDC of Metoprolol Tartrate IP + Ivabradine HCL eq to Ivabradine (25mg+5mg & 50mg+5mg) Film coated tablets 1316 KB
235 FDC of Metoprolol Succinate ER + Cilnidipine +Telmisartan (25mg + 10mg + 40mg & 50mg + 10mg + 40mg) Tablets 1300 KB
236 Edoxaban 1794 KB
237 Mirikizumab 1850 KB
238 LCZ696 1762 KB
239 Mirikizumab 1786 KB
240 EG12014 1782 KB
241 Osilodrostat (LCI699 1794 KB
242 Paracetamol Injection 500mg/2ml for IM route Phase III 1960 KB
243 Pilot study on Paracetamol Injection for IM route Pilot study 1593 KB
244 Bilastine 20 mg 312 KB
245 Magnesium sulfate 116 KB
246 Dolutegravir (Phase IV) 78.6 KB
247 TRC041266 195 KB
248 KAF156 1902 KB
249 Nitazoxanide 500 mg Tablets 1696 KB
250 Scrub Typhus INTREST 1820 KB
251 Granexin Gel 545 KB
252 Aztreonam-Avibactam (ATM-AVI 2029 KB
253 Brolucizumab 1822 KB
254 5-aminolevulinic acid hydrochloride 1854 KB
255 Ticagrelor 1672 KB
256 Tagrisso (Osimertinib) 137 KB
257 Sodium Copper Chlorophyllin 155 KB
258 Kyprolis (Carfilzomib) 184 KB
259 Pregabalin IP (As Prolonged Release) 75mg + Etoricoxib IP 60mg uncoated bilayered tablets (Phase-III). 1,195 KB
260 Metoprolol Succinate ER + Chlorthalidone + Telmisartan (50mg+12.5mg+40mg, 25mg+12.5mg+40mg)film coated tablets (Phase-III) 1,027 KB
261 Efonidipine Hydrochloride Ethanolate 20mg + Telmisartan IP 40mg film coated Tablets (Phase-III) 1,008 KB
262 Alcaftadine 0.25% w/v + Ketoroloc Tromethamine 0.4% w/v Eye drops (Phase-III). 1,163 KB
263 Azilsartan Medoxomil + Chlorthalidone (40mg+25mg,40mg+12.5mg 40mg+6.25mg) Tablets (Phase-III). 1,118 KB
264 Tadalafil + Dapoxetine (20mg +60mg, 20mg+30mg, 10mg+30mg) film coated tablets (Phase-III). 949 KB
265 Cinacalcet Hydrochloride 1,710 KB
266 Durvalumab 260 KB
267 Filgotinib 1,786 KB
268 emaglutide 2.4 mg CT/18/000019 1,708 KB
269 Semaglutide 2.4 mg 1,722 KB
270 Semaglutide 2.4 mg 1,708 KB
271 Efpeglenatide 444 KB
272 Sotagliflozin 1,910 KB
273 Enzalutamide 98.6 KB
274 Desidustat 106 KB
275 Delamanid 82 KB
276 Azelnidipine tab 16 mg 130 KB
277 Calcipotriol/AKVANO 50 µg/g cutaneous solution 1,737,836 KB
278 Efpeglenatide 444 KB
279 Permission for conducting A Phase 3 clinical trial titled "ATLAS- INH: A Phase 3 Study to Evaluate the Efficacy and Safety of Fitusiran in Patients With Hemophilia A or B, With Inhibitory Antibodies to Factor VIII or IX 143KB
280 Permission for conducting a Phase rB/IlA 'clinical study entitled , "A Phase IS /IrA, multi-center , open-label clinical trial to evaluate the safety, to lerability and pharmacokinetic of Desidustat for the patients with Chronic Kidney Disease (CKD) on Dialysis " 97KB
281 Permission for conducting a clinical study entitle d, "A multicentric , Randomized , double blind , parallel group, comparative, Phase 3 clinical study to evaluate the efficacy, Safety and Tolerability of Azelnidipine Tablets 16 mg verus Amlodipine Tablets 10 mg in subjects with essential hypertension " 128KB
282 Permission for conducting a clinical study entitled "A Phase-l/ll open label, single arm study to evaluate the pharmacokinetic, safety and tolerability of Delamanid in combination with optimized Multidrug Background Regimen (OBR) for multidrug-Resistant Tuberculosis (MDRTB) in HIV infected and HIV-uninfected children with MDR-TB" 76KB
283 Ivermectin topical lotion 0.5% w/w 1,858,593 KB
284 Darunavir Tablet 800mg 143KB
285 Erdafitinib 1803 KB
286 Permission for conducting a clinical study entitled , "A multicenter Phase-4 , Open-label, Single-arm, Safety and Efficacy Study of Enzalutarnide in Indian Patients with Progressive Metastatic Castration -Resistant Prostate Cancer (mCRPC) Previously Treated with Docetaxel-Based Chemotherapy" 105KB
287 Canakinumab 1877 KB
288 Rigosertib 1688 KB
289 Paliperidone Palmitate 1757 KB
290 Atezolizumab 1769 KB
291 Fitusiran 1875 KB
292 Torsemide Extended Release 568KB
293 SCY 078 242KB
294 Exenatide 373KB
295 YLB113 299KB
296 Rilpivirine 577KB
297 MB02 (Bevacizumab Biosimilar Drug) 573KB
298 Emicizumab 371KB
299 NexoBrid 302KB
300 Baricitinib 300KB
301 AMG 334 392KB
302 Baricitinib 300KB
303 QAW039 570KB
304 Fitusiran 1758 KB
305 Pimodivir15 1640 KB
306 Pimodivir 1718 KB
307 CLS-TA 1814 KB
308 ASN100 1753 KB
309 MEDI-551 1763 KB
310 Regorafenib 140KB
311 Fluticasone Propionate 100 mcg and Salmeterol 50 mcg 1750 KB
312 QVM149 1804 KB
313 Lenvatinib 143KB
314 Sofosbuvir / Velpatasvir FDC 100KB
315 Februric (Febuxostat) 103KB
316 Pirfenidone 100KB
317 Anagliptin 162KB
318 Verapamil ER 193KB
319 Heptral 105KB
320 Spironolactone cream 5% 926KB
321 Heptral 105kb
322 BIO-11006 565 KB
323 Ataluren 269 KB
324 LUBT010 371 KB
325 Selinexor (KPT-330) 445 KB
326 Nintedanib Systemic Sclerosis 404 KB
327 ABP 798 340 KB
328 ribociclib with endocrine 423 KB
329 Povidone-Iodine Nail Solution 103 KB
330 Dapagliflozin 5 and 10 mg 447 KB
331 Dinutuximab and Irinotecan 456 KB
332 Canagliflozin in Children 439 KB
333 SB11 282 KB
334 Atezolizumab compared with chemotherapy 109 KB
335 Lorlatinib (PF-06463922) 470 KB
336 Denosumab 320 KB
337 CLS-TA Sapphire 100 KB
338 Selinexor 448 KB
339 Bempedoic Acid (ETC-1002) 582 KB
340 LJN452 367 KB
341 Atezolizumab(ANTI-PD-L1Antibody) 907 KB
342 Deferasirox Formulation(Granules) 842 KB
343 Ticagrlor 1115 KB
344 Ruxolitinib 849 KB
345 LCZ696 on NT Pro BNP 1117 KB
346 Alpelisib 861 KB
347 QAW039 sept 1132 KB
348 Ixekizumab 1165 KB
349 PEGylated factor 1154 KB
350 Abemaciclib 1210 KB
351 Apixaban 1104 KB
352 RSV 868 KB
353 Empagliflozin 10mg 1138 KB
354 Empagliflozin 1228 KB
355 LY900014 (Insulin Lispro) 1115 KB
356 ANF-Rho 1125 KB
357 Canagliflozin 1121 KB
358 SAIT101 vs Rituximab 1353 KB
359 Dapagliflozin PC D1699C00001 1064 KB
360 QMF149 150-80 microgram 1039 KB
361 MOD-4023 1274 KB
362 ovidone -Iodine 1133 KB
363 Safety Study of Atezolizumab 814 KB
364 Eltrombopag 867 KB
365 Dulaglutide 985 KB
366 SPI-2012 876 KB
367 LNP1892 1018 KB
368 Ribociclib 846 KB
369 Filgotinib combined phase 1008 KB
370 Filgotinib Rheumatoid 842 KB
371 Secukinumab 888 KB
372 Filgotinib Crohn 1203 KB
373 sFilgotinib 1171 KB
374 LNP3794 819 KB
375 Filgotinib Administered 196 KB
376 LY900014 1048 KB
377 Tenofovir Alafenamide 1111 KB
378 Filgotinib 198 KB
379 Dapagliflozin 1168 KB
380 CLS-TA 59 KB
381 Selonsertib 1320 KB
382 Masitinib vs Placebo 807 KB
383 Pemafibrate 1356 KB
384 Ribociclib LEE011 831 KB
385 Filgotinib safety 1238 KB
386 Selonsertib NASH 1326 KB
387 Bedaquiline 152 KB
388 Daprodustat 183 KB
389 aprodustat 227 KB
390 Oral Semaglutide versus 192 KB
391 LCZ696 145 KB
392 SAIT101 148 KB
393 Alphanate® 139 KB
394 TK-112690 172 KB
395 Etrolizumab 207 KB
396 Ofatumumab 188 KB
397 Ofatumumab safety 186 KB
398 Pradaxa Capsules 155 KB
399 Etrolizumab PhaseII/III 204 KB
400 Clindamycin phosphate 178 KB
401 DE-117 200 KB
402 Lixisenatide 204 KB
403 QVA149 294 KB
404 Aclidinium 229 KB
405 Nintedanib oral 197 KB
406 Sarizotan 142 KB
407 Avelumab 150 KB
408 CBT124 222 KB
409 Insulin Degludec 156 KB
410 LY2835219 295 KB
411 FIASP 143 KB
412 Palbociclib 178 KB
413 Report Book 5,165kb
414 Guidance for global access of OCTAMS 1,138kb
415 Guidance Document for Export NOC 137kb
416 Manual of OCTAMS 4,561kb
417 Guidance document for Functions and Responsibilities of Zonal, Sub-zonal & port offices of CDSCO 4,818kb
418 Sofosbuvir Velpatasvir 158 KB
419 Cardiovascular safety of Oral Semaglutide 216 KB
420 Vedolizumab IV 152 KB
421 Budesonide 150 KB
422 MYL-14020 280 KB
423 Dexamethasone sodium 141 KB
424 Pegylated Interferon @-2a 143 KB
425 BCD-055 148 KB
426 NC0195-0092 130 KB
427 Liraglutide 136 KB
428 QAW039 128 KB
429 Oral Semaglutide 133 KB
430 GS-5745 138 KB
431 RFB002 135 KB
432 Semaglutide IGlar SGT2i 160 KB
433 Trimcinolone Acetonide 173 KB
434 Rivaroxaban 148 KB
435 MEDI4736 aug 211 KB
436 MEDI4736 189 KB
437 Ceritinib 144 KB
438 INC280 2112 KB
439 Ticagrelor 158 KB
440 QMF149 225 KB
441 Indacaterol 277 KB
442 BIASP-30 198 KB
443 Insulin Aspart 195 KB
444 NW-3509A 153 KB
445 MDR-TB Drugs 151 KB
446 Insulin degludec may 216 KB
447 Lopinavir/Ritonavir 144 KB
448 B1695502 225 KB
449 Sofosbuvir 143 KB
450 RLX030 190 KB
451 Clindamycin 189 KB
452 Semaglutide 2016 256 KB
453 Masitinib 178 KB
454 Carbetocin RTS 1542 KB
455 YLB113 184 KB
456 Insulin degludec 245 KB
457 BYL719 189 KB
458 LEE011 183 KB
459 Nintedanib 204 KB
460 Pregabali 182 KB
461 Pregabalin 182 KB
462 Bevacizumab 181 KB
463 Recruitment Rule of Drugs Inspector in CDSCO 2,512kb
464 Alirocumab 191 KB
465 CT P10 186 KB
466 QGE031 CQGE031B2201 166 KB
467 QGE031 S.c 191 KB
468 FG-3019s 190 KB
469 Roxadustat Anemia 190 KB
470 Roxadustat 187 KB
471 Dydrogesterone 178 KB
472 GENA-05 160 KB
473 Subcutaneous Secukinumab 221 KB
474 Pregabalin as adjunctive 171 KB
475 Linaclotide 225 KB
476 LCZ696 NYHA 204 KB
477 LCZ696 Paradigm 235 KB
478 Moroctocog alfa 166 KB
479 RanibizumAB 173 KB
480 Canagloflozin 209 KB
481 Steroids in Iga 181 KB
482 Insulin Aspart BIAsp 201 KB
483 Salmeterol 193 KB
484 Masitinib Lymphoma 189 KB
485 LEE011 NSAI 182 KB
486 Amended Checklist for test License Applications Effective From 15 June2011 69kb
487 Guidance Document on Grant of Licenses in Form 11(Test License) 618kb
488 Checklist for Test License Appli8cations Effective From 15 June 2011 143kb
489 Octafibrin 170 KB
490 DE-109 180 KB
491 ACTG 5288 170 KB
492 Dabigatran etexilate dual 239 KB
493 Clindamycin 1% 215 KB
494 Bococizumab PF-04950615) 368 KB
495 LEE011 with Lerozole 184 KB
496 Bococizumab 369 KB
497 Masitinib 210 KB
498 Masitinib Folfiri 209 KB
499 Fibrinogen 182 KB
500 Chemotherapy 178 KB
501 Dabigatran Etexilate 255 KB
502 Dabigatran 197 KB
503 Rituximab 190 KB
504 2 PARALLEL Masitinib 213 KB
505 Chemoradiation 162 KB
506 Ticagelor 189 KB
507 QGE031 183 KB
508 Isoniazid 172 KB
509 Tiotropium 265 KB
510 Labetalol 162 KB
511 Nifedipine Daga 165 KB
512 DS-5565 178 KB
513 Nifedipine Daga 165 KB
514 LY2963019 200 KB
515 NNC0195-0092 188 KB
516 Insulin Detemir 181 KB
517 Pasireotidestudy 171 KB
518 Mifepristone 160 KB
519 Pasireotide 173 KB
520 Mifepristone and Misoprotol 163 KB
521 LCI699 173 KB
522 Policy Initiatives Planned for 2015 85kb
523 LY2605541 200 KB
524 Octafibrin GCT/64/14 197 KB
525 Semaglutide 2014 198 KB
526 Antidepressant 149 KB
527 Alglucosidase Alfa 164 KB
528 Dabigatran BI 655075 223 KB
529 Ranibizumab VEGF 180 KB
530 Ranibizumab Brilliance 191 KB
531 Ranibizumab CRVO 180 KB
532 Afatinib for Patients 172 KB
533 Rituximab RTXM83 185 KB
534 Trastuzumab 216 KB
535 Afatinib BiBW 2992 189 KB
536 Alglucosidase 171 KB
537 Herpes Zoster 169 KB
538 Pregabalin Adjunctive 188 KB
539 Paclitaxel 178 KB
540 Eravacycline 197 KB
541 UT-15C Phase III 189 KB
542 UT-15C 176 KB
543 Dapagliflozin 10mg 201 KB
544 Bevacizumab AVASTIN 178 KB
545 LDK378 219 KB
546 Pertuzumab 180 KB
547 Pasireotide LAR 163 KB
548 FactorVIII 122 KB
549 Ifetroban Injection 192 KB
550 Baricitinib in Patients 222 KB
551 Adalimumab 179 KB
552 Cyclosporine 190 KB
553 Fluocinolone acetonide intravitreal 174 KB
554 Ranibizumab 0.5 mg 188 KB
555 Everolimus with reduced calcineurin 256 KB
556 Fosaprepitant 191 KB
557 Sitagliptin 213 KB
558 Masitinib 198 KB
559 Liraglutide Sitagliptin 181 KB
560 NOVA22007 191 KB
561 QAW039 on FEV1 184 KB
562 Clindamycin benzoyal peroxide 265 KB
563 BCD-020 223 KB
564 Pasireotide S.C 173 KB
565 Ciprodex 212 KB
566 Enbrel 194 KB
567 Daclizumab 186 KB
568 Remicade 215 KB
569 Exenatide 174 KB
570 Ceftazidime CAZ AVI 200 KB
571 BCD-021 214 KB
572 Buparlisib 182 KB
573 Liraglutide versus sulphonylurea 211 KB
574 Insulin Degludec versus insulin glargine 277 KB
575 BCD-022 217 KB
576 tolerability of Secukinumab 176 KB
577 Everolimus alone 183 KB
578 Everolimus RADOO1 192 KB
579 Transfer Policy 421kb
580 SAR236553 681 KB
581 subcutaneous Secukinumab 166 KB
582 Afatinib 225 KB
583 Sofosbuvir plus ribavirin 291 KB
584 Ceftazidime 283 KB
585 Everolimus 243 KB
586 Fluocinolone 292 KB
587 FLU D-QIV 278 KB
588 FIAsP 2014 279 KB
589 FIAsP Insulin 280 KB
590 Tenofovir Disoproxil 303 KB
591 Tenofovir Alafenamide TAF 314 KB
592 olasertib 289 KB
593 Baricitinib 357 KB
594 Diclofenac Gel 370 KB
595 Baricitinib LY3009104 348 KB
596 BEZ235 846 KB
597 TechnologyMG145 1410 KB
598 Producttrastuzumab 926 KB
599 LAF237 293 KB
600 Liraglutide sc Injection 306 KB
601 Human rh FV III 301 KB
602 Fesoterodine 305 KB
603 Octefibrin 290 KB
604 Tenofovir 342 KB
605 Lixisenatid Subcutaneous 382 KB
606 CP-690,550 296 KB
607 ART-123 303 KB
608 Quotation of rate contract for supply of Photostat Paper (JK Brand) Last date (27 Jul 2012 ) 129kb
609 Re-tendering for Housekeeping and General cleanliness in the CDSCO(HQ), FDA Bhawan, Kotla Road, New Delhi Last Date ( 27 Jul 2012 ) 903kb
610 Extension of Date of Notice Inviting Tender (NIT) Last Date( 27 Jul 2012 ) 370kb
611 Annual Rate Contract for Hiring taxies 1 Last Date( 27 Jul 2012 ) 132kb
612 Annual Rate Contract for Hiring taxies 2 Last Date ( 27 Jul 2012 ) 1,775kb
613 Annual Rate Contract for Hiring taxies 3 Last Date( 27 Jul 2012 ) 162kb